Skip to content

Prevalence of malignancy among adrenal nodules detected in patients with potentially resectable colorectal cancer: Should we perform additional imaging study?

Prevalence of malignancy among adrenal nodules detected in patients with potentially resectable colorectal cancer: Should we perform additional imaging study?

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0006516
Enrollment
7000
Registered
2021-08-30
Start date
2021-06-01
Completion date
Unknown
Last updated
2021-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Seoul National University Bundang Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who have staging CT, defined as that performed within three months before any definitive treatment (i.e., surgery or chemotherapy) of colorectal cancer, or within three months before or after endoscopic biopsy or resection.

Exclusion criteria

Exclusion criteria: We will exclude patients who did not undergo staging CT of abdomen and pelvis. We will also exclude patients having unresectable colorectal cancer at the time of staging CT, based on two study coordinators’ review of the medical records. Potentially resectable cancer includes not only cases without overt extra-adrenal metastasis, but also hepatic or pulmonary metastasis that could be excised radically. For determining whether hepatic or pulmonary metastasis is resectable, we will use prospective decisions made in the multidisciplinary meetings during patients’ staging workup. For patients with rectal cancer, those who underwent neoadjuvant concurrent chemoradiotherapy (CCRT) with curative intention will also included.

Design outcomes

Primary

MeasureTime frame
prevalence of adrenal nodule (the number of patients with CT-detected adrenal nodule out of patients who underwent staging CT and had potentially resectable colorectal cancer )

Secondary

MeasureTime frame
proportion of malignant nodule (the number of patients with malignant adrenal nodule out of patients with CT-detected adrenal nodules)

Countries

Korea, Republic of

Contacts

Public ContactHae Young Kim

Seoul National University Bundang Hospital

qkfmrp860329@@gmail.com+82-31-787-8143

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026